New Agents for the Treatment of Tuberculosis on Clinical Study Phases II/III

E-ISSN： 1875-6387 |3|2|101-106

ISSN： 1573-398x

Source： Current Respiratory Medicine Reviews, Vol.3, Iss.2, 2007-05, pp. : 101-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Drugs and Treatment Regimens

Current Respiratory Medicine Reviews, Vol. 9, Iss. 3, 2013-08 ,pp. : 200-210

Bentham Science Publishers

Access to resources Recommend Favorite

Human Leukocyte Antigens Class I and Class II: Associations and Distribution in Different Ethnic Groups of Patients with Pulmonary Tuberculosis

Current Respiratory Medicine Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 117-121

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in Developed and Developing Countries: Finally Towards Equality?

Current Respiratory Medicine Reviews, Vol. 8, Iss. 6, 2013-01 ,pp. : 464-474

Bentham Science Publishers

Access to resources Recommend Favorite

Severe Influenza: Clinical Features and Treatment Options

Current Respiratory Medicine Reviews, Vol. 8, Iss. 3, 2012-05 ,pp. : 208-227

Bentham Science Publishers

Access to resources Recommend Favorite

Bringing Down the Wall of the Mycobacterium tuberculosis Fortress: Old and New Inhibitors of Mycolic Acid Biosynthesis

Current Respiratory Medicine Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 190-200

Bentham Science Publishers

Access to resources Recommend Favorite